
    
      The contrast agent (Gd-DTPA, Gadavist) will be injected intravenously (IV) in the arm
      (patients only). The IV will be inserted by qualified medical professional at CBI. This
      contrast agent will be standard dose in accordance with its FDA approved labeling and dosing.
      Controls will NOT be administered the contrast agent.
    
  